First Eagle Investment Management
RMD icon

First Eagle Investment Management’s ResMed RMD Stock Holding History

First Eagle Investment Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-22,000
Closed -$983K – 372
2014
Q1 		$983K Hold
22,000
– – ﹤0.01% 209
2013
Q4 		$1.04M Hold
22,000
– – ﹤0.01% 210
2013
Q3 		$1.16M Hold
22,000
– – ﹤0.01% 213
2013
Q2 		$993K Buy
+22,000
New +$1.04M ﹤0.01% 242

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $355M AUM
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

First Eagle Investment Management's RMD Position: Q2 2014 in Review

First Eagle Investment Management sold out of ResMed (RMD) in Q2 2014, closing a stake of 22,000 shares — an estimated $983K sold.

First Eagle Investment Management first reported a position in RMD in Q2 2013 and held it in 4 quarters. The position peaked at $1.16M in Q3 2013. 313 funds tracked by Wall St. Rank hold RMD as of Q2 2014.

  • First Eagle Investment Management reported no remaining ResMed position as of Q2 2014 after selling out during the quarter.
  • First Eagle Investment Management sold 22,000 ResMed shares in Q2 2014, an estimated $983K.
  • First Eagle Investment Management first reported a position in ResMed in Q2 2013 and held it in 4 quarters.
  • First Eagle Investment Management's ResMed position peaked at $1.16M in Q3 2013.
  • 313 funds tracked by Wall St. Rank held ResMed as of Q2 2014.

Based on First Eagle Investment Management's 13F filing for Q2 2014, filed 8 Aug 2014.